| Year |
Citation |
Score |
| 2016 |
Kodama K, Zhao Z, Toda K, Yip L, Fuhlbrigge R, Miao D, Fathman CG, Yamada S, Butte AJ, Yu L. Expression-based Genome-Wide Association Study Links Vitamin D Binding Protein with Autoantigenicity in Type 1 Diabetes. Diabetes. PMID 26983959 DOI: 10.2337/Db15-1308 |
0.394 |
|
| 2016 |
Creusot RJ, Battaglia M, Roncarolo MG, Fathman CG. Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes. Stem Cells (Dayton, Ohio). 34: 809-19. PMID 26840009 DOI: 10.1002/Stem.2290 |
0.321 |
|
| 2015 |
Kurnellas MP, Ghosn EE, Schartner JM, Baker J, Rothbard JJ, Negrin RS, Herzenberg LA, Fathman CG, Steinman L, Rothbard JB. Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 26621719 DOI: 10.1073/Pnas.1521206112 |
0.374 |
|
| 2015 |
Nair N, Mei HE, Chen SY, Hale M, Nolan GP, Maecker HT, Genovese M, Fathman CG, Whiting CC. Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy. Arthritis Research & Therapy. 17: 127. PMID 25981462 DOI: 10.1186/S13075-015-0644-Z |
0.315 |
|
| 2015 |
Yip L, Fuhlbrigge R, Taylor C, Creusot RJ, Nishikawa-Matsumura T, Whiting CC, Schartner JM, Akter R, von Herrath M, Fathman CG. Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes. Diabetes. 64: 604-17. PMID 25187368 DOI: 10.2337/Db14-0803 |
0.347 |
|
| 2014 |
Kurnellas MP, Schartner JM, Fathman CG, Jagger A, Steinman L, Rothbard JB. Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. The Journal of Experimental Medicine. 211: 1847-56. PMID 25073790 DOI: 10.1084/Jem.20140107 |
0.309 |
|
| 2014 |
Yip L, Fathman CG. Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis. Immunologic Research. 58: 340-50. PMID 24682832 DOI: 10.1007/S12026-014-8501-8 |
0.377 |
|
| 2014 |
Creusot RJ, Giannoukakis N, Trucco M, Clare-Salzler MJ, Fathman CG. It's time to bring dendritic cell therapy to type 1 diabetes. Diabetes. 63: 20-30. PMID 24357690 DOI: 10.2337/Db13-0886 |
0.441 |
|
| 2013 |
Yip L, Taylor C, Whiting CC, Fathman CG. Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes. Diabetes. 62: 4208-19. PMID 24264405 DOI: 10.2337/Db13-0614 |
0.358 |
|
| 2013 |
Yip L, Creusot RJ, Pager CT, Sarnow P, Fathman CG. Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3. Journal of Molecular Cell Biology. 5: 99-110. PMID 22923498 DOI: 10.1093/Jmcb/Mjs052 |
0.347 |
|
| 2012 |
Junttila IS, Creusot RJ, Moraga I, Bates DL, Wong MT, Alonso MN, Suhoski MM, Lupardus P, Meier-Schellersheim M, Engleman EG, Utz PJ, Fathman CG, Paul WE, Garcia KC. Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nature Chemical Biology. 8: 990-8. PMID 23103943 DOI: 10.1038/Nchembio.1096 |
0.308 |
|
| 2012 |
Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Moraga I, Raeber ME, Bowman GR, Novick P, Pande VS, Fathman CG, Boyman O, Garcia KC. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature. 484: 529-33. PMID 22446627 DOI: 10.1038/Nature10975 |
0.327 |
|
| 2012 |
Lin JT, Stein EA, Wong MT, Kalpathy KJ, Su LL, Utz PJ, Robinson WH, Fathman CG. Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis. Clinical Immunology (Orlando, Fla.). 142: 127-38. PMID 22075384 DOI: 10.1016/J.Clim.2011.09.008 |
0.449 |
|
| 2011 |
Whiting CC, Su LL, Lin JT, Fathman CG. GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness. The Febs Journal. 278: 47-58. PMID 21078124 DOI: 10.1111/J.1742-4658.2010.07922.X |
0.483 |
|
| 2010 |
Creusot RJ, Chang P, Healey DG, Tcherepanova IY, Nicolette CA, Fathman CG. A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2112-20. PMID 20628358 DOI: 10.1038/Mt.2010.146 |
0.352 |
|
| 2010 |
Fathman CG. Correction: omitted author. Science (New York, N.Y.). 260: 280. PMID 17838233 DOI: 10.1126/Science.260.5106.280-A |
0.366 |
|
| 2010 |
Lin J, Stein E, Wong M, Kalpathy K, Su L, Utz P, Robinson W, Fathman C. Targeting mTOR and MAPK Pathways to Inhibit Naïve and Experienced Effector CD4 T Cells in Autoimmunity Clinical Immunology. 135: S69. DOI: 10.1016/J.Clim.2010.03.211 |
0.329 |
|
| 2009 |
Yip L, Su L, Sheng D, Chang P, Atkinson M, Czesak M, Albert PR, Collier AR, Turley SJ, Fathman CG, Creusot RJ. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nature Immunology. 10: 1026-33. PMID 19668219 DOI: 10.1038/Ni.1773 |
0.313 |
|
| 2009 |
Su LL, Iwai H, Lin JT, Fathman CG. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 438-44. PMID 19542455 DOI: 10.4049/Jimmunol.0900204 |
0.455 |
|
| 2009 |
Lin JT, Lineberry NB, Kattah MG, Su LL, Utz PJ, Fathman CG, Wu L. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. Journal of Immunology (Baltimore, Md. : 1950). 182: 5919-28. PMID 19414743 DOI: 10.4049/Jimmunol.0803986 |
0.45 |
|
| 2009 |
Acharya S, Fathman CG. F.124. CTLA-4 Ig Serves as a Surrogate for Tregs by Engaging Activation Induced CD80/86 on Murine T Effector Cells Clinical Immunology. 131: S127. DOI: 10.1016/J.Clim.2009.03.375 |
0.444 |
|
| 2009 |
Su L, Iwai H, Lin J, Fathman CG. F.80. The TransmembraneE3 Ligase, GRAIL Ubiquitinates and Degrades CD83 on CD4+ T cells Clinical Immunology. 131: S115. DOI: 10.1016/J.Clim.2009.03.338 |
0.411 |
|
| 2009 |
Creusot R, Chang P, Yaghoubi S, Healey D, Tcherepanova I, Nicolette C, Fathman CG. T.14. A Short Pulse of IL-4 Delivered Locally by mRNA Electroporated DCs is Sufficient to Prevent or Treat Autoimmune Diabetes in NOD Mice Clinical Immunology. 131: S53. DOI: 10.1016/J.Clim.2009.03.149 |
0.34 |
|
| 2009 |
Lin J, Lineberry N, Kattah M, Su L, Utz P, Fathman CG. OR.85. Regulation of GRAIL Expression by mTOR Controls Naive CD4 T Cell Proliferation Clinical Immunology. 131: S35-S36. DOI: 10.1016/J.Clim.2009.03.100 |
0.45 |
|
| 2008 |
Kodama K, Butte AJ, Creusot RJ, Su L, Sheng D, Hartnett M, Iwai H, Soares LR, Fathman CG. Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clinical Immunology (Orlando, Fla.). 129: 195-201. PMID 18801706 DOI: 10.1016/J.Clim.2008.07.028 |
0.304 |
|
| 2008 |
Lineberry N, Su L, Soares L, Fathman CG. The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane. The Journal of Biological Chemistry. 283: 28497-505. PMID 18713730 DOI: 10.1074/Jbc.M805092200 |
0.318 |
|
| 2008 |
Lineberry NB, Su LL, Lin JT, Coffey GP, Seroogy CM, Fathman CG. Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 181: 1622-6. PMID 18641297 DOI: 10.4049/Jimmunol.181.3.1622 |
0.485 |
|
| 2008 |
Creusot RJ, Yaghoubi SS, Kodama K, Dang DN, Dang VH, Breckpot K, Thielemans K, Gambhir SS, Fathman CG. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clinical Immunology (Orlando, Fla.). 127: 176-87. PMID 18337172 DOI: 10.1016/J.Clim.2007.12.009 |
0.331 |
|
| 2008 |
Acharya S, Hacohen N, Soares L, Fathman C. OR.37. shRNA Mediated Downregulation of Genes Identified as ‘Core Transcriptome’ in Murine T Regulatory Cells Clinical Immunology. 127. DOI: 10.1016/J.Clim.2008.03.503 |
0.312 |
|
| 2008 |
Creusot R, Chang P, Fathman C. Sa.86. The Earliest Islet-infiltrating T Cells in NOD Mice Clinical Immunology. 127: S108-S109. DOI: 10.1016/j.clim.2008.03.307 |
0.31 |
|
| 2007 |
Yaghoubi SS, Creusot RJ, Ray P, Fathman CG, Gambhir SS. Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. Journal of Biomedical Optics. 12: 064025. PMID 18163841 DOI: 10.1117/1.2821415 |
0.387 |
|
| 2007 |
Dutt S, Tseng D, Ermann J, George TI, Liu YP, Davis CR, Fathman CG, Strober S. Naive and memory T cells induce different types of graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 6547-54. PMID 17982043 DOI: 10.4049/Jimmunol.179.10.6547 |
0.456 |
|
| 2007 |
Li J, Ridgway W, Fathman CG, Tse HY, Shaw MK. High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 192: 57-67. PMID 17920698 DOI: 10.1016/J.Jneuroim.2007.09.004 |
0.488 |
|
| 2007 |
Fathman CG, Lineberry NB. Molecular mechanisms of CD4+ T-cell anergy. Nature Reviews. Immunology. 7: 599-609. PMID 17612584 DOI: 10.1038/Nri2131 |
0.478 |
|
| 2007 |
MacKenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, Seroogy CM. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. The Journal of Biological Chemistry. 282: 9696-702. PMID 17259178 DOI: 10.1074/Jbc.M604192200 |
0.496 |
|
| 2007 |
Creusot RJ, Yaghoubi S, Kodama K, Gambhir SS, Dang D, Fathman CG. Targeted Cellular Gene Therapy Using IL-4 Secreting DCs Corrects Immune Dysregulations and Prevents Diabetes in NOD Mice Clinical Immunology. 123: S17. DOI: 10.1016/J.Clim.2007.03.218 |
0.326 |
|
| 2007 |
Iwai H, Kodama K, Dang D, Fathman CG, Bluestone JA. Gene Expression Analysis by Microarray Following Anti-CD3 Antibody Therapy of NOD Mice Clinical Immunology. 123: S9. DOI: 10.1016/J.Clim.2007.03.197 |
0.394 |
|
| 2006 |
Su L, Lineberry N, Huh Y, Soares L, Fathman CG. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 177: 7559-66. PMID 17114425 DOI: 10.4049/Jimmunol.177.11.7559 |
0.387 |
|
| 2006 |
Tarner IH, Fathman CG. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? Nature Clinical Practice. Rheumatology. 2: 491-9. PMID 16951704 DOI: 10.1038/Ncprheum0272 |
0.355 |
|
| 2006 |
Lineberry N, Fathman CG. T cell anergy: where it's LAT. Immunity. 24: 501-3. PMID 16713965 DOI: 10.1016/J.Immuni.2006.05.002 |
0.416 |
|
| 2006 |
Lineberry N, Fathman CG. CYLD: deubiquitination-induced TCR signaling. Nature Immunology. 7: 369-70. PMID 16550202 DOI: 10.1038/Ni0406-369 |
0.314 |
|
| 2006 |
Tarner IH, Neumann E, Gay S, Fathman CG, Müller-Ladner U. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis. Autoimmunity Reviews. 5: 148-52. PMID 16431349 DOI: 10.1016/J.Autrev.2005.09.009 |
0.303 |
|
| 2006 |
Randolph DA, Fathman CG. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annual Review of Medicine. 57: 381-402. PMID 16409156 DOI: 10.1146/Annurev.Med.57.121304.131337 |
0.486 |
|
| 2006 |
Dutt S, Tseng D, George TI, Ermann J, Liu Y, Fathman CG, Strober S. Allosensitized Memory CD4 T Cells Induce Chronic Graft Versus Host Disease. Blood. 108: 449-449. DOI: 10.1182/Blood.V108.11.449.449 |
0.46 |
|
| 2006 |
Abrahamsson A, Geron I, Gotlib J, Durocher J, Creusot R, Kavalerchik E, Goff D, Fathman C, Lilleberg SL, Giles F, Weissman I, Jamieson C. Aberrant Regulation of Wnt/Beta-Catenin Pathway Mediators in Chronic Myelogenous Leukemia Stem Cells. Blood. 108: 2135-2135. DOI: 10.1182/BLOOD.V108.11.2135.2135 |
0.383 |
|
| 2006 |
Lineberry N, Fathman CG. T Cell Anergy: Where It's LAT (DOI:10.1016/j.immuni.2006.05.002) Immunity. 25: 175. DOI: 10.1016/J.Immuni.2006.07.008 |
0.385 |
|
| 2005 |
Dutt S, Ermann J, Tseng D, Liu YP, George TI, Fathman CG, Strober S. L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 106: 4009-15. PMID 16105972 DOI: 10.1182/Blood-2005-06-2339 |
0.463 |
|
| 2005 |
Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP, Negrin RS, Fathman CG, Strober S. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood. 105: 2220-6. PMID 15546950 DOI: 10.1182/Blood-2004-05-2044 |
0.449 |
|
| 2005 |
Jamieson C, Karimi M, Creusot R, Negrin R, Gotlib J, Chao M, Jones C, Keating A, Fathman CG, Zehnder J, Weissman IL. Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. Blood. 106: 696-696. DOI: 10.1182/Blood.V106.11.696.696 |
0.509 |
|
| 2005 |
Dutt S, Tseng D, Ermann J, Liu YP, George TI, Fathman CG, Strober S. Memory CD4 T Cells Induce Graft Versus Host Disease. Blood. 106: 1309-1309. DOI: 10.1182/Blood.V106.11.1309.1309 |
0.466 |
|
| 2005 |
Jamieson C, Karimi M, Creusot R, Fathman C, Negrin R, Weissman I. Bioluminescent tracking of candidate leukemic stem cell engraftment in immunocompromised mice Biology of Blood and Marrow Transplantation. 11: 86. DOI: 10.1016/J.Bbmt.2004.12.254 |
0.355 |
|
| 2004 |
Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. Protein microarrays for multiplex analysis of signal transduction pathways. Nature Medicine. 10: 1390-6. PMID 15558056 DOI: 10.1038/Nm1139 |
0.413 |
|
| 2004 |
Su L, Creusot RJ, Gallo EM, Chan SM, Utz PJ, Fathman CG, Ermann J. Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. Journal of Immunology (Baltimore, Md. : 1950). 173: 4994-5001. PMID 15470042 DOI: 10.4049/Jimmunol.173.8.4994 |
0.435 |
|
| 2004 |
Creusot RJ, Fathman CG. Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity. The Journal of Clinical Investigation. 114: 892-4. PMID 15467826 DOI: 10.1172/Jci23168 |
0.418 |
|
| 2004 |
Jeon MS, Atfield A, Venuprasad K, Krawczyk C, Sarao R, Elly C, Yang C, Arya S, Bachmaier K, Su L, Bouchard D, Jones R, Gronski M, Ohashi P, Wada T, ... ... Fathman CG, et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction Immunity. 21: 167-177. PMID 15308098 DOI: 10.1016/J.Immuni.2004.07.013 |
0.414 |
|
| 2004 |
Seroogy CM, Soares L, Ranheim EA, Su L, Holness C, Bloom D, Fathman CG. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 79-85. PMID 15210761 DOI: 10.4049/Jimmunol.173.1.79 |
0.5 |
|
| 2004 |
Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, Engleman E, Fathman CG. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nature Immunology. 5: 45-54. PMID 14661020 DOI: 10.1038/Ni1017 |
0.48 |
|
| 2003 |
Seroogy CM, Fathman CG. T-cell anergy: from phenotype to genotype and back. Immunologic Research. 28: 255-64. PMID 14713718 DOI: 10.1385/Ir:28:3:255 |
0.395 |
|
| 2003 |
Ermann J, Chung CD, Fathman CG. Scratching the (T cell) surface. Genome Biology. 5: 202. PMID 14709166 DOI: 10.1186/Gb-2003-5-1-202 |
0.434 |
|
| 2003 |
Ermann J, Fathman CG. Costimulatory signals controlling regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 15292-3. PMID 14676329 DOI: 10.1073/Pnas.0307001100 |
0.464 |
|
| 2003 |
Tarner IH, Slavin AJ, McBride J, Levicnik A, Smith R, Nolan GP, Contag CH, Fathman CG. Treatment of autoimmune disease by adoptive cellular gene therapy. Annals of the New York Academy of Sciences. 998: 512-9. PMID 14592922 DOI: 10.1196/Annals.1254.067 |
0.475 |
|
| 2003 |
Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine. 9: 1144-50. PMID 12925844 DOI: 10.1038/Nm915 |
0.476 |
|
| 2003 |
Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, Seroogy C, Skrenta H, Hollenhorst M, Fathman CG, Soares L. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity. 18: 535-47. PMID 12705856 DOI: 10.1016/S1074-7613(03)00084-0 |
0.457 |
|
| 2002 |
Slavin AJ, Tarner IH, Nakajima A, Urbanek-Ruiz I, McBride J, Contag CH, Fathman CG. Adoptive cellular gene therapy of autoimmune disease. Autoimmunity Reviews. 1: 213-9. PMID 12848998 DOI: 10.1016/S1568-9972(02)00051-4 |
0.44 |
|
| 2002 |
McBride JM, Fathman CG. A complicated relationship: fulfilling the interactive needs of the T lymphocyte and the dendritic cell. The Pharmacogenomics Journal. 2: 367-76. PMID 12629502 DOI: 10.1038/sj.tpj.6500145 |
0.368 |
|
| 2002 |
Tarner IH, Nakajima A, Seroogy CM, Ermann J, Levicnik A, Contag CH, Fathman CG. Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Clinical Immunology (Orlando, Fla.). 105: 304-14. PMID 12498812 DOI: 10.1006/Clim.2002.5299 |
0.354 |
|
| 2002 |
Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K, Fathman CG, Mueller SN, Shortman K, Carbone FR, Heath WR. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. The Journal of Experimental Medicine. 196: 1099-104. PMID 12391021 DOI: 10.1084/Jem.20020861 |
0.423 |
|
| 2002 |
Oh JW, Seroogy CM, Meyer EH, Akbari O, Berry G, Fathman CG, Dekruyff RH, Umetsu DT. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. The Journal of Allergy and Clinical Immunology. 110: 460-8. PMID 12209095 DOI: 10.1067/Mai.2002.127512 |
0.422 |
|
| 2002 |
Szanya V, Ermann J, Taylor C, Holness C, Fathman CG. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. Journal of Immunology (Baltimore, Md. : 1950). 169: 2461-5. PMID 12193715 DOI: 10.4049/Jimmunol.169.5.2461 |
0.42 |
|
| 2002 |
Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. The Journal of Experimental Medicine. 196: 389-99. PMID 12163567 DOI: 10.1084/Jem.20020399 |
0.47 |
|
| 2001 |
Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH. Bioluminescence imaging of lymphocyte trafficking in vivo. Experimental Hematology. 29: 1353-60. PMID 11750093 DOI: 10.1016/S0301-472X(01)00756-1 |
0.327 |
|
| 2001 |
Tarner IH, Fathman CG. Gene therapy in autoimmune disease. Current Opinion in Immunology. 13: 676-82. PMID 11677089 DOI: 10.1016/S0952-7915(01)00278-3 |
0.353 |
|
| 2001 |
Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 167: 4271-5. PMID 11591749 DOI: 10.4049/Jimmunol.167.8.4271 |
0.454 |
|
| 2001 |
Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ, Contag CH, Fathman CG, Benson JM. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. Journal of Immunology (Baltimore, Md. : 1950). 167: 2379-87. PMID 11490028 DOI: 10.4049/Jimmunol.167.4.2379 |
0.487 |
|
| 2001 |
Urbanek-Ruiz I, Ruiz PJ, Paragas V, Garren H, Steinman L, Fathman CG. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. Clinical Immunology (Orlando, Fla.). 100: 164-71. PMID 11465945 DOI: 10.1006/Clim.2001.5055 |
0.312 |
|
| 2001 |
Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. The Journal of Clinical Investigation. 107: 1293-301. PMID 11375419 DOI: 10.1172/Jci12037 |
0.486 |
|
| 2000 |
Fassò M, Anandasabapathy N, Crawford F, Kappler J, Fathman CG, Ridgway WM. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. The Journal of Experimental Medicine. 192: 1719-30. PMID 11120769 DOI: 10.1084/Jem.192.12.1719 |
0.494 |
|
| 2000 |
Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100: 655-69. PMID 10761931 DOI: 10.1016/S0092-8674(00)80702-3 |
0.39 |
|
| 2000 |
Fathman CG, Costa GL, Seroogy CM. Gene therapy for autoimmune disease. Clinical Immunology (Orlando, Fla.). 95: S39-43. PMID 10729236 DOI: 10.1006/Clim.1999.4812 |
0.5 |
|
| 2000 |
Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 164: 3581-90. PMID 10725713 DOI: 10.4049/Jimmunol.164.7.3581 |
0.517 |
|
| 2000 |
Skrenta H, Yang Y, Pestka S, Fathman CG. Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement. Journal of Immunology (Baltimore, Md. : 1950). 164: 3506-11. PMID 10725704 DOI: 10.4049/Jimmunol.164.7.3506 |
0.418 |
|
| 2000 |
Krieger NR, Fathman CG, Shaw MK, Ridgway WM. Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo. Transplantation. 69: 605-9. PMID 10708118 |
0.41 |
|
| 2000 |
Seroogy CM, Fathman CG. The application of gene therapy in autoimmune diseases. Gene Therapy. 7: 9-13. PMID 10680009 DOI: 10.1038/sj.gt.3301111 |
0.338 |
|
| 1999 |
Ridgway WM, Fathman CG. MHC structure and autoimmune T cell repertoire development. Current Opinion in Immunology. 11: 638-42. PMID 10631548 DOI: 10.1016/S0952-7915(99)00030-8 |
0.392 |
|
| 1999 |
Lejon K, Fathman CG. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. Journal of Immunology (Baltimore, Md. : 1950). 163: 5708-14. PMID 10553102 |
0.417 |
|
| 1999 |
Dal Canto RA, Shaw MK, Nolan GP, Steinman L, Fathman CG. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. Clinical Immunology (Orlando, Fla.). 90: 10-4. PMID 9884347 DOI: 10.1006/Clim.1998.4653 |
0.406 |
|
| 1998 |
Ridgway WM, Ito H, Fassò M, Yu C, Fathman CG. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. The Journal of Experimental Medicine. 188: 2267-75. PMID 9858513 DOI: 10.1084/Jem.188.12.2267 |
0.461 |
|
| 1998 |
Dal Canto RA, Costa G, Shaw MD, Seroogy C, Nolan GP, Fathman CG. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis. European Cytokine Network. 9: 83-91. PMID 9831193 |
0.323 |
|
| 1998 |
Ridgway W, Fassò M, Fathman CG. Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. Journal of Immunology (Baltimore, Md. : 1950). 161: 714-20. PMID 9670947 |
0.36 |
|
| 1998 |
Yang Y, Chang JF, Parnes JR, Fathman CG. T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. The Journal of Experimental Medicine. 188: 247-54. PMID 9670037 DOI: 10.1084/Jem.188.2.247 |
0.357 |
|
| 1998 |
Charlton B, Fathman CG, Slattery RM. Th1 unresponsiveness can be infectious for unrelated antigens. Immunology and Cell Biology. 76: 173-8. PMID 9619488 DOI: 10.1046/j.1440-1711.1998.00728.x |
0.302 |
|
| 1998 |
Yang Y, Kim D, Fathman CG. Regulation of programmed cell death following T cell activation in vivo. International Immunology. 10: 175-83. PMID 9533445 DOI: 10.1093/intimm/10.2.175 |
0.315 |
|
| 1998 |
Ridgway WM, Fathman CG. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clinical Immunology and Immunopathology. 86: 3-10. PMID 9434791 DOI: 10.1006/Clin.1997.4449 |
0.402 |
|
| 1997 |
Ito H, Fathman CG. CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. Journal of Autoimmunity. 10: 455-9. PMID 9376073 DOI: 10.1016/S0896-8411(97)90152-9 |
0.4 |
|
| 1997 |
Krieger NR, Ito H, Fathman CG. Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. Journal of Autoimmunity. 10: 309-15. PMID 9218759 DOI: 10.1006/Jaut.1997.0126 |
0.406 |
|
| 1997 |
Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 185: 1711-4. PMID 9151908 DOI: 10.1084/Jem.185.9.1711 |
0.419 |
|
| 1997 |
Krieger NR, Fathman CG. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 16: 263-7. PMID 9087868 |
0.344 |
|
| 1996 |
Yin DP, Sankary HN, Williams J, Krieger N, Fathman CG. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. Transplantation. 62: 1537-9. PMID 8970603 DOI: 10.1097/00007890-199612150-00001 |
0.334 |
|
| 1996 |
Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. The Journal of Experimental Medicine. 184: 2013-8. PMID 8920888 |
0.319 |
|
| 1996 |
Shimada A, Charlton B, Rohane P, Taylor-Edwards C, Fathman CG. Immune regulation in type 1 diabetes Journal of Autoimmunity. 9: 263-269. PMID 8738972 DOI: 10.1006/jaut.1996.0033 |
0.322 |
|
| 1996 |
Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes. 45: 1063-7. PMID 8690153 DOI: 10.2337/diab.45.8.1063 |
0.307 |
|
| 1996 |
Yang Y, Charlton B, Shimada A, Dal Canto R, Fathman CG. Monoclonal T cells identified in early NOD islet infiltrates Immunity. 4: 189-194. PMID 8624809 DOI: 10.1016/S1074-7613(00)80683-4 |
0.474 |
|
| 1996 |
Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell D, Veromaa T, Waisman A, Gaur A, Conlon P, Ling N, ... ... Fathman CG, et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379: 343-6. PMID 8552189 DOI: 10.1038/379343a0 |
0.307 |
|
| 1996 |
Shimada A, Rohane P, Fathman CG, Charlton B. Pathogenic and protective roles of CD45RBlow CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse Diabetes. 45: 71-78. PMID 8522063 DOI: 10.2337/diab.45.1.71 |
0.308 |
|
| 1994 |
Gelber C, Paborsky L, Singer S, Mcateer D, Tisch R, Jolicoeur C, Buelow R, Mcdevitt H, Fathman CG. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes Diabetes. 43: 33-39. PMID 8262314 |
0.315 |
|
| 1994 |
Charlton B, Meltzer J, Fathman CG. CD4-positive/heat-stable antigen-positive thymocytes cause graft-versus-host disease across non-major histocompatibility complex incompatibilities. European Journal of Immunology. 24: 1706-9. PMID 7913040 DOI: 10.1002/Eji.1830240738 |
0.475 |
|
| 1994 |
Charlton B, Edwards CT, Tisch R, Fathman CG. Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD Mice Journal of Autoimmunity. 7: 549-560. PMID 7840850 DOI: 10.1006/Jaut.1994.1040 |
0.413 |
|
| 1994 |
Ridgway WM, Weiner HL, Fathman CG. Regulation of autoimmune response Current Opinion in Immunology. 6: 946-955. PMID 7710719 DOI: 10.1016/0952-7915(94)90018-3 |
0.339 |
|
| 1993 |
Chen RH, Ivens KW, Alpert S, Billingham ME, Fathman CG, Flavin TF, Shizuru JA, Starnes VA, Weissman IL, Griffiths GM. The use of granzyme A as a marker of heart transplant rejection in cyclosporine or anti-CD4 monoclonal antibody-treated rats. Transplantation. 55: 146-53. PMID 8420039 |
0.633 |
|
| 1993 |
Song HK, Alters SE, Fathman CG. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice1 Transplantation. 55: 133-139. PMID 8420037 |
0.37 |
|
| 1993 |
Gaur A, Haspel R, Mayer JP, Fathman CG. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness Science. 259: 91-94. PMID 8418501 DOI: 10.1126/science.8418501 |
0.36 |
|
| 1993 |
Alters SE, Song HK, Fathman CG. Evidence that clonal anergy is induced in thymic migrant cells after anti-cd4-mediated transplantation tolerance Transplantation. 56: 633-638. PMID 8212161 DOI: 10.1097/00007890-199309000-00026 |
0.39 |
|
| 1993 |
Shizuru JA, Fathman CG. Anti-CD4 antibodies in diabetes Immunology Series. 59: 237-252. PMID 8096401 |
0.517 |
|
| 1993 |
Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen Nature. 365: 642-644. PMID 7692305 DOI: 10.1038/365642A0 |
0.444 |
|
| 1993 |
Gaur A, Fathman CG, Steinman L, Brocke S. SEB induced anergy: Modulation of immune response to T cell determinants of myoglobin and myelin basic protein Journal of Immunology. 150: 3062-3069. PMID 7681087 |
0.339 |
|
| 1992 |
Fathman CG. What a rheumatologist needs to know about T cell receptor structure and function Journal of Rheumatology. 19: 12-15. PMID 1613729 |
0.34 |
|
| 1992 |
Sellins KS, Danska JS, Paragas V, Fathman CG. Limited T cell receptor β-chain usage in the sperm whale myoglobin 110-121/EαdAβd response by H-2d congenic mouse strains Journal of Immunology. 149: 2323-2327. PMID 1382096 |
0.592 |
|
| 1992 |
Shizuru JA, Alters SE, Fathman CG. Anti-CD4 monoclonal antibodies in therapy: Creation of nonclassical tolerance in the adult Immunological Reviews. 105-130. PMID 1361179 DOI: 10.1111/J.1600-065X.1992.Tb01421.X |
0.635 |
|
| 1991 |
Ruberti G, Gaur A, Fathman CG, Livingstone AM. The T cell receptor repertoire influences Vβ element usage in response to myoglobin Journal of Experimental Medicine. 174: 83-92. PMID 2056283 |
0.317 |
|
| 1991 |
Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction Journal of Experimental Medicine. 173: 491-494. PMID 1899105 DOI: 10.1084/Jem.173.2.491 |
0.598 |
|
| 1991 |
Seydel K, Shizuru J, Grossman D, Wu A, Alters S, Fathman CG. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model Diabetes. 40: 1430-1434. PMID 1834499 DOI: 10.2337/Diab.40.11.1430 |
0.593 |
|
| 1991 |
Shizuru JA, Taylor-Edwards C, Livingstone A, Fathman CG. Genetic dissection of T cell receptor Vβ gene requirements for spontaneous murine diabetes Journal of Experimental Medicine. 174: 633-638. PMID 1831491 DOI: 10.1084/Jem.174.3.633 |
0.565 |
|
| 1991 |
Livingstone A, Edwards CT, Shizuru JA, Fathman CG. Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor β gene expression Journal of Immunology. 146: 529-534. PMID 1824775 |
0.504 |
|
| 1991 |
Ruberti G, Livingstone A, Danska JS, Gaur A, Fathman CG. Analysis of the ternary complex of antigen, MHC and T-cell receptor: the influence of the T-cell receptor Vβ repertoire on the Vβ gene element usage Research in Immunology. 142: 491-493. PMID 1721721 DOI: 10.1016/0923-2494(91)90054-M |
0.622 |
|
| 1990 |
Morel PA, Horn GT, Budd RC, Erlich HA, Fathman CG. Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. Human Immunology. 27: 90-9. PMID 2298612 DOI: 10.1016/0198-8859(90)90106-Y |
0.38 |
|
| 1990 |
Guidos CJ, Danska JS, Fathman CG, Weissman IL. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages Journal of Experimental Medicine. 172: 835-845. PMID 2143774 DOI: 10.1084/Jem.172.3.835 |
0.673 |
|
| 1990 |
Flavin T, Shizuru J, Seydel K, Wu A, Fujimoto N, Hoyt EG, Ivens K, Billingham M, Fathman CG, Starnes VA. Selective T-cell depletion with Ox-38 anti-CD4 monoclonal antibody prevents cardiac allograft rejection in rats Journal of Heart Transplantation. 9: 482-488. PMID 1977898 |
0.542 |
|
| 1990 |
Shizuru JA, Seydel KB, Flavin TF, Wu AP, Kong CC, Hoyt EG, Fujimoto N, Billingham ME, Starnes VA, Fathman CG. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-004 monoclonal antibody therapy Transplantation. 50: 366-373. PMID 1976282 |
0.515 |
|
| 1990 |
Danska JS, Livingstone AM, Paragas V, Ishihara T, Fathman CG. The presumptive CDR3 regions of both T cell receptor α and β chains determine T cell specificity for myoglobin peptides Journal of Experimental Medicine. 172: 27-33. PMID 1694219 |
0.592 |
|
| 1989 |
Butterfield K, Fathman CG, Budd RC. A subset of memory CD4+ helper T lymphocytes identified by expression of Pgp-1 Journal of Experimental Medicine. 169: 1461-1466. PMID 2564418 |
0.385 |
|
| 1989 |
Trager DK, Banks BA, Rosenbaum GE, Holm BI, Shizuru JA, Strober S, Fathman CG. Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy. Transplantation. 47: 587-91. PMID 2523098 |
0.502 |
|
| 1989 |
Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone AM, Fathman CG, Inaba K, Steinman RM. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells Journal of Experimental Medicine. 169: 1169-1178. PMID 2522497 |
0.317 |
|
| 1989 |
Weyand CM, Goronzy J, Swarztrauber K, Fathman CG. Immunosuppression by anti-CD4 treatment in vivo: Cellular and humoral responses to alloantigens Transplantation. 47: 1039-1042. PMID 2472024 |
0.362 |
|
| 1989 |
Weyand CM, Goronzy J, Swarztrauber K, Fathman CG. Immunosuppression by anti-CD4 treatment in vivo: Persistence of secondary antiviral immune responses Transplantation. 47: 1034-1038. PMID 2472023 |
0.394 |
|
| 1988 |
Livingstone A, Fathman CG. Murine T cell clones. Methods in Enzymology. 150: 324-33. PMID 3501521 DOI: 10.1016/0076-6879(87)50090-8 |
0.367 |
|
| 1988 |
Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science (New York, N.Y.). 240: 659-62. PMID 2966437 DOI: 10.1126/Science.2966437 |
0.536 |
|
| 1988 |
Morel PA, Erlich HA, Fathman CG. A new look at the shared epitope hypothesis The American Journal of Medicine. 85: 20-22. PMID 2462347 DOI: 10.1016/0002-9343(88)90375-0 |
0.374 |
|
| 1987 |
Ishihara T, Fathman CG. Production of antibodies in vitro in cultures of murine lymphocytes Methods in Enzymology. 150: 304-309. PMID 3323787 DOI: 10.1016/0076-6879(87)50087-8 |
0.402 |
|
| 1987 |
Goronzy J, Weyand C, Imboden J, Manger B, Fathman CG. Heterogeneity of signal requirements in T cell activation within a panel of human proliferative T cell clones Journal of Immunology. 138: 3087-3093. PMID 3106471 |
0.335 |
|
| 1987 |
Weyand CM, Goronzy J, Fathman CG. Modulation of CD4 by antigenic activation Journal of Immunology. 138: 1351-1354. PMID 3100638 |
0.39 |
|
| 1987 |
Shizuru JA, Gregory AK, Chao CTB, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4 Science. 237: 278-280. PMID 2955518 DOI: 10.1126/Science.2955518 |
0.546 |
|
| 1986 |
Kyewski BA, Fathman CG, Rouse RV. Intrathymic presentation of circulating non-MHC antigens by medullary dendritic cells. An antigen-dependent microenvironment for T cell differentiation Journal of Experimental Medicine. 163: 231-246. PMID 3484777 |
0.327 |
|
| 1986 |
Goronzy J, Weyand CM, Fathman CG. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 Journal of Experimental Medicine. 164: 911-925. PMID 3091757 |
0.339 |
|
| 1986 |
Shizuru JA, Ramakrishnan S, Hunt T, Merrell RG, Fathman CG. Inhibition of rat mixed lymphocyte pancreatic islet cultures with anti-Ia immunotoxin Transplantation. 42: 660-666. PMID 2947362 |
0.531 |
|
| 1986 |
Shigeta M, Takahara S, Knox SJ, Ishihara T, Vitetta ES, Fathman CG. Two independent pathways of helper activity provided by a single T cell clone. Journal of Immunology (Baltimore, Md. : 1950). 136: 34-8. PMID 2933466 |
0.314 |
|
| 1986 |
Fathman CG, Goronzy J, Weyand C. Gene conversion: A mechanism to explain HLA-D region and disease association Annals of the New York Academy of Sciences. 24-31. PMID 2431644 DOI: 10.1111/J.1749-6632.1986.Tb20853.X |
0.389 |
|
| 1986 |
Kimoto M, Fathman CG. One I Region Restriction Determinant Can Associate with Multiple Antigenic Epitopes Microbiology and Immunology. 30: 133-142. PMID 2423856 DOI: 10.1111/J.1348-0421.1986.Tb00928.X |
0.412 |
|
| 1986 |
Ishihara T, Takahara S, Fathman CG. IL 2 restores memory B cell activation by antigen-specific T cell clone variants Journal of Immunology. 136: 39-43. PMID 2415626 |
0.323 |
|
| 1985 |
Frelinger JG, Shigeta M, Fathman CG. An analysis of monoclonal T cell and antibody recognition sites on Ia molecules Journal of Investigative Dermatology. 85. PMID 3874247 DOI: 10.1111/1523-1747.Ep12275430 |
0.388 |
|
| 1985 |
Nakahara K, Kaplan D, Bjorn M, Fathman CG. The effectiveness of anti–Ia–immunotoxins in the suppression of MLR Transplantation. 40: 62-67. PMID 3160144 DOI: 10.1097/00007890-198507000-00013 |
0.373 |
|
| 1985 |
Cunningham AL, Nelson PA, Fathman CG, Merigan TC. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. The Journal of General Virology. 66: 249-58. PMID 2981967 DOI: 10.1099/0022-1317-66-2-249 |
0.382 |
|
| 1984 |
Kyewski BA, Fathman CG, Kaplan HS. Intrathymic presentation of circulating non-major histocompatibility complex antigens Nature. 308: 196-199. PMID 6608055 DOI: 10.1038/308196A0 |
0.319 |
|
| 1984 |
Mengle-Gaw L, Conner S, McDevitt HO, Fathman CG. Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant. The Journal of Experimental Medicine. 160: 1184-94. PMID 6434690 DOI: 10.1084/Jem.160.4.1184 |
0.463 |
|
| 1983 |
Fathman CG, Frelinger JG. T-lymphocyte clones Annual Review of Immunology. 1: 633-655. PMID 6242467 DOI: 10.1146/Annurev.Iy.01.040183.003221 |
0.312 |
|
| 1983 |
Beck BN, Nelson PA, Fathman CG. The I-Ab mutant B6.C-H-2bm12 allows definition of multiple T cell epitopes on I-A molecules. The Journal of Experimental Medicine. 157: 1396-404. PMID 6189934 |
0.313 |
|
| 1983 |
Infante AJ, Atassi MZ, Fathman CG. Myoglobin-reactive T cell clones. Advances in Experimental Medicine and Biology. 150: 159-82. PMID 6183942 DOI: 10.1007/978-1-4684-4331-8_9 |
0.31 |
|
| 1982 |
Hodes RJ, Kimoto M, Hathcock KS, Fathman CG, Singer A. Functional helper activity of monoclonal T cell populations: antigen-specific and H-2 restricted cloned T cells provide help for in vitro antibody responses to trinitrophenyl-poly(LTyr,Glu)-poly(DLAla)--poly(LLys). Proceedings of the National Academy of Sciences of the United States of America. 78: 6431-5. PMID 6975940 DOI: 10.1073/pnas.78.10.6431 |
0.329 |
|
| 1982 |
Singer A, Asano Y, Shigeta M, Hathcock KS, Ahmed A, Fathman CG, Hodes RJ. Distinct B cell subpopulations differ in their genetic requirements for activation by T helper cells. Immunological Reviews. 64: 137-60. PMID 6806171 DOI: 10.1111/J.1600-065X.1982.Tb00422.X |
0.388 |
|
| 1982 |
Shigeta M, Fathman CG. I-region genetic restrictions imposed upon the recognition of KLH by murine T-cell clones. Immunogenetics. 14: 415-22. PMID 6800947 DOI: 10.1007/BF00373321 |
0.328 |
|
| 1982 |
Dailey MO, Fathman CG, Butcher EC, Pillemer E, Weissman I. Abnormal migration of T lymphocyte clones. Journal of Immunology (Baltimore, Md. : 1950). 128: 2134-6. PMID 6460817 |
0.484 |
|
| 1982 |
Infante AJ, Infante PD, Gillis S, Fathman CG. Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones. The Journal of Experimental Medicine. 155: 1100-7. PMID 6174671 DOI: 10.1084/Jem.155.4.1100 |
0.335 |
|
| 1982 |
Infante AJ, Atassi MZ, Fathman CG. T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin. The Journal of Experimental Medicine. 154: 1342-56. PMID 6170716 DOI: 10.1084/JEM.154.5.1342 |
0.305 |
|
| 1981 |
Fathman CG, Kimoto M. Studies Utilizing murine T cell clones: Ir genes, Ia antigens and MLR stimulating determinants. Immunological Reviews. 54: 57-79. PMID 6166538 DOI: 10.1111/j.1600-065X.1981.tb00434.x |
0.301 |
|
| 1981 |
Fathman CG, Kimoto M, Melvold R, David CS. Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation. Proceedings of the National Academy of Sciences of the United States of America. 78: 1853-7. PMID 6165020 DOI: 10.1073/PNAS.78.3.1853 |
0.328 |
|
| 1980 |
Fathman CG, Weissman IL. Production of alloreactive T-cell lymphomas. Nature. 283: 404-6. PMID 6965424 DOI: 10.1038/283404a0 |
0.499 |
|
| 1980 |
Kimoto M, Fathman CG. Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. The Journal of Experimental Medicine. 152: 759-70. PMID 6158548 DOI: 10.1084/JEM.152.4.759 |
0.315 |
|
| 1978 |
Fathman CG, Hengartner H. Clones of alloreactive T cells. Nature. 272: 617-8. PMID 306067 DOI: 10.1038/272617A0 |
0.311 |
|
| 1978 |
Watanabe T, Fathman CG, Coutinho A. T cells which proliferate in response to concanavalin A include cells which proliferate in mixed leucocyte reactions. European Journal of Immunology. 7: 603-7. PMID 144602 DOI: 10.1002/eji.1830070905 |
0.31 |
|
| 1975 |
Fathman CG, Small M, Herzenberg LA, Weissman IL. Thymus cell maturation. II. Differentiation of three "mature" subclasses in vivo. Cellular Immunology. 15: 109-28. PMID 1109155 DOI: 10.1016/0008-8749(75)90169-0 |
0.471 |
|
| 1975 |
Weissman IL, Small M, Fathman CG, Herzenberg LA. Differentiation of thymus cells-1,2. Federation Proceedings. 34: 141-4. PMID 1090451 |
0.373 |
|
| 1975 |
Cantor H, Simpson E, Sato VL, Fathman CG, Herzenberg LA. Characterization of subpopulations of T lymphocytes. I. Separation and functional studies of peripheral T-cells binding different amounts of fluorescent anti-Thy 1.2 (theta) antibody using a fluorescence-activated cell sorter (FACS). Cellular Immunology. 15: 180-96. PMID 1088903 DOI: 10.1016/0008-8749(75)90174-4 |
0.446 |
|
| Show low-probability matches. |
